Navigation Links
UBM Canon, the Global MedTech Authority, and the Medical Design Excellence Awards Announce Dean Kamen as the Presenter of the 2012 Lifetime Achievement Award
Date:4/11/2012

LOS ANGELES, April 11, 2012 /PRNewswire/ -- UBM Canon's Medical Design Excellence Awards (MDEA), the industry's premier awards ceremony for medical device design and innovation, has announced that Dean Kamen will present the 2012 MDEA Lifetime Achievement Award to Dr. Thomas Fogarty during the MDEA award ceremony on May 23, 2012.

(Photo: http://photos.prnewswire.com/prnh/20120411/LA84898)

(Logo: http://photos.prnewswire.com/prnh/20101214/LA16070LOGO)

"I am pleased to announce that Mr. Kamen will be presenting Dr. Fogarty with the Lifetime Achievement Award in Philadelphia," stated Heather Thompson, Editor in Chief, Medical Device and Diagnostic Industry. "Mr. Kamen's work has revolutionized the medical device industry. It is an honor to have two medical pioneers on hand with us; making the 2012 MDEAs a momentous event."

Dean Kamen is an inventor, an entrepreneur, and advocate for science and technology. He has more than 440 U.S. and foreign patents and invented the first wearable infusion pump and the first wearable insulin pump for diabetes. Some of the many devices Mr. Kamen has worked on include the HomeChoice™ peritoneal dialysis system, Hydroflex™ surgical irrigation pump, the Crown™ stent, iBOT™ mobility device, and the Segway® Human Transporter. Mr. Kamen was awarded the National Medal of Technology in 2000, the Lemelson-MIT Prize 2002, and has been inducted into the National Inventors Hall of Fame in 2005.

Mr. Kamen will present Dr. Fogarty with the Lifetime Achievement Award at the 2012 MDEA awards ceremony during the MD&M East conference and tradeshow in Philadelphia on May 23. Before the awards ceremony, Dr. Fogarty and Mr. Kamen will participate in a live Q&A panel lead by UBM's Director of Content, Rich Nass. The panel will be held from 2:30- 3:00pm on the MD&M East show floor.

To learn more about Mr. Kamen's achievements, click here.

The 2012 Medical Design Excellence Awards are sponsored by Platinum Sponsor: Phillips-Medisize and Silver Sponsor: Teleflex Medical OEM.

About Medical Design Excellence Awards

Sponsored by MD+DI and organized by UBM Canon, MDEA is the premier awards program for the medical technology community. It recognizes the achievements of medical device manufacturers, their suppliers, and the many people behind the scenes—engineers, scientists, designers, and clinicians—who are responsible for the groundbreaking innovations that are changing the face of healthcare. MDEA-winning entries excel in the areas of product innovation, design and engineering achievement, end-user benefit, and cost-effectiveness in manufacturing and healthcare delivery.

About UBM Canon

UBM Canon, the leading B2B media company dedicated exclusively to the global $3.0 trillion advanced manufacturing sector, helps support the flow of information, commerce and innovation in such sophisticated segments as medical devices and pharmaceutical development. UBM Canon also addresses cutting-edge developments in broader areas of advanced engineering design and manufacturing, and manufacturing processes and packaging. UBM Canon is part of UBM plc (UBM.L) a global provider of media and information services for professional B2B communities and markets.


'/>"/>
SOURCE UBM Canon
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Experts Strengthen Albright Stonebridge Groups Global Reach
2. All Global Partners With HealthEngage to Provide Unique Web 2.0 Patient Insights
3. Fundamental steps needed now in global redesign of Earth system governance
4. MiMedx Signs Agreement with Systagenix for Global Distribution of EpiFix®
5. Scholars call for global governance overhaul to ensure Earths sustainability
6. More than half of Americans doubt US global leadership in 2020
7. Global Biotechnology Industry
8. Global Leaders in Advanced Biofuels Industry Urge Congressional Leaders to Extend Critical Tax Provisions
9. Neurocrine Biosciences to Present at the Citi 2012 Global Health Care Conference
10. Life Technologies to Present at Barclays Capital Global Healthcare Conference
11. Avanir Pharmaceuticals to Participate in Citi 2012 Global Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , ... December 08, 2016 , ... ... FrontPanel SDK that provide essential device-to-computer interconnect using USB or PCI Express, announced ... FrontPanel support. The FOMD-ACV-A4 is a small, thin, SODIMM-style module that fits a ...
(Date:12/8/2016)... , ... December 08, 2016 ... ... the commercial launch of flexible packaging for their exceptionally efficient human mesenchymal ... system extends RoosterBio’s portfolio of bioprocess media products engineered to radically streamline ...
(Date:12/8/2016)... Fla. , Dec. 8, 2016  HedgePath ... company that discovers, develops and plans to commercialize ... its shares of common stock were approved for ... will begin trading on the OTCQX, effective today, ... qualify for the OTCQX market, companies must meet ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... its phase I/II dose escalation and expansion clinical trial for its lead drug ... Austria. The purpose of the trial was to determine the safety, antitumor activity, ...
Breaking Biology Technology:
(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s high-speed AFIS    ... ... DERMALOG is Germany's largest Multi-Biometric supplier: The company's Fingerprint ... ... Multi-Biometric supplier: The company's Fingerprint Identification System is part of an efficient ...
(Date:11/21/2016)... VILNIUS, Lithuania , Nov. 21, 2016 /PRNewswire/ ... identification and object recognition technologies, today announced that ... for smart cards was submitted for the ... and successfully passed all the mandatory steps of ... III evaluation is a continuing test of fingerprint ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
Breaking Biology News(10 mins):